Skip to main content
Figure 7 | Journal of Neuroinflammation

Figure 7

From: Effects of the PPAR-β agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination

Figure 7

Expression of PPAR-β mRNA in microglial cells after antibody-mediated demyelination. The antibody-mediated demyelination did not modify the cellular expression of PPAR-β analyzed by in situ hybridization. Macrophagic microglial cells labeled by ED1 were more numerous in cultures subjected to the demyelinating treatment (C compared to A and B, respectively). A, untreated control; B, complement treated (guinea pig serum, 25 μl/ml); C, treated with antibody (anti-MOG, 62.5 μg/ml) and complement. Bar = 50 μm.

Back to article page